Company Filing History:
Years Active: 2015-2016
Title: The Innovations of Matthew D. Erickson
Introduction
Matthew D. Erickson, an inventive mind based in Hermantown, Minnesota, has made significant contributions to the field of sample processing and analysis. With a total of five patents to his name, he continues to push the boundaries of technology used in biological research.
Latest Patents
Among his latest patents are innovative systems and methods for processing and analyzing samples, particularly focused on biological fluids. His patents detail the development of a reaction vessel that enables the use of assay cartridges in various processing locations. This flexibility allows samples to be prepared and analyzed in distinct areas, enhancing the efficiency of procedures such as PCR processing. The systems also include essential components like thermal cycler modules and optical detection systems, designed to accurately determine nucleic acid sequences in samples. These advancements can lead to rapid and precise sample processing, making a substantial impact in the field of biological analysis.
Career Highlights
Matthew currently works at Beckman Coulter, Inc., a company renowned for its innovations in laboratory instruments and diagnostic solutions. His role within the organization allows him to collaborate on groundbreaking technologies that contribute to advancements in medical and laboratory science.
Collaborations
Throughout his career, Matthew has had the privilege to work alongside talented colleagues, including Brian D. Wilson and Alan N. Johnson. Their collaborative efforts contribute to a rich environment of innovation and idea exchange, further driving the success of their projects.
Conclusion
Matthew D. Erickson's inventive contributions, particularly in the realm of sample processing and analysis, underscore the critical role of innovation in science and medicine. As he continues to develop new technologies at Beckman Coulter, the potential for groundbreaking advancements in biological research remains promising.